Oncology Information Systems Market

Growing incidence of cancer to propel market growth

The global increase in cancer cases is one of the main factors driving the market for oncology information systems. Globally, there were 19.29 million new cases of cancer in 2020, and GLOBOCAN 2020 predicts that number would rise to 28.4 million by 2040 (an increase of 47%). It is projected that 50.6 million individuals worldwide have cancer (5-year prevalence, or the total number of people living with cancer from the last 5 years). In a similar vein, the American Cancer Society reports that in 2021, there were over 1.9 million new instances of cancer diagnosed in the United States alone.

The development of a wide range of revolutionary technologies has the ability to totally change the treatment plan. As a result of the rising incidence of cancer, there will be a demand for OIS to streamline patient information and data management, which would ultimately propel the market of oncology information systems. A few other reasons, such as the growing demand to reduce the cost of cancer treatment and the rising popularity of electronic health records EHR) and other oncology information systems, are also playing significant roles in propelling the market for oncology information systems forward.

Thus, this factor is driving the market CAGR for oncology information systems.

Furthermore, the market's expansion is driven by the availability of numerous OIS with increased features. OIS has gradually taken the place of paper and manual medical records because of digitalization. These systems are made to make it simple to handle patient treatment plans, timetables, delivery, summaries, and test results. These systems' built-in software streamlines and simplifies the labour process, which helps in providing patients with high-quality care. Personal and medical histories, clinical diagnoses, actual and anticipated treatment plans, and post-therapy outcomes are all fully and accurately described by OIS. These programmes keep track of numerous patient oncology treatment regimens.

However, there is an increasing need for various forms of OIS software as a result of the increased demand for OIS to streamline patient information and data management. Market expansion is anticipated to be fueled by increased corporate expenditure in cancer research. Businesses are increasingly investing in the creation of cutting-edge items because the market is anticipated to grow greatly in the upcoming years. Thus, it is anticipated that this aspect will accelerate oncology information systems market revenue globally.

News

The cancer information system RayCare may now link to Varian TrueBeam linear accelerators, according to RaySearch Laboratories AB. This is the outcome of the signed interoperability contract with Varian Medical Systems. An important feature of an oncology information system is the capability to organize radiation treatments and monitor therapy progress. Data transfer among the OIS and the treatment delivery system, in the present instance, the Varian TrueBeam linear accelerators (linacs), is required to allow an integrated workflow.

In February 2024, the All India Institute of Medical Sciences (AIIMS) Delhi, in partnership with the Centre for Development of Advanced Computing, Pune, introduced iOncology.ai, an Artificial Intelligence (AI) platform specifically developed to identify breast and ovarian cancer at an early stage.   

In January 2024, HIMSS, a prominent organization dedicated to transforming the worldwide healthcare system through information and technology, introduced a revamped Infrastructure Adoption Model (INFRAM). The recently updated INFRAM places its emphasis on five essential areas that significantly contribute to the value and results of healthcare organizations: cybersecurity, adoption, sustainability, performance, and outcomes.

An integrated information and image management tool called an oncology information system makes it easier to manage and improve cancer patients' therapy and patient profiles. To manage patient portfolios, OIS software is used in healthcare facilities like hospitals, physician offices, and research labs. The OIS helps healthcare organizations like hospitals, clinics, and academic labs manage and improve cancer care services and share patient data across organizations to improve patient safety, personalized care for each patient, and optimize therapy. The market's growth is fueled by governments increasing their outlay in oncology-related studies and development.

The need for healthcare IT services is expected to rise during the forecast time frame due to factors like how well oncology information systems are replacing traditional data handling methods and validations, which reduces manual labor and automates the process.

Additionally, this software is utilized to share patient data on cancer patients between healthcare organizations and forecast treatment outcomes. The prevalence of cancer cases and the wide range of treatment options have forced healthcare providers to start using an effective data management system to manage large data sets, including medical records and treatment practices, which is a major driver of the expanding scope of the oncology information systems market. Electronic health record and medical record maintenance, patient treatment pattern maintenance, and treatment prediction are all goals of these data management systems, often known as OIS.

These advantages raise the patient-centered safety and effectiveness of cancer treatment. OIS aids medical professionals in making the best treatment decisions to increase survival rates.

The increasing prevalence of cancer globally serves as a primary driver for the Global Oncology Information Systems Market Industry. As cancer cases rise, healthcare systems are compelled to adopt advanced information systems to enhance patient management and treatment outcomes. For instance, the World Health Organization reports that cancer cases are expected to reach 29.5 million by 2040. This surge necessitates efficient data management and treatment planning, propelling the market's growth. The Global Oncology Information Systems Market is projected to reach 6.44 USD Billion in 2024, highlighting the urgent need for innovative solutions in oncology.

The Global Oncology Information Systems Market Industry is projected to experience substantial growth in the coming years. With an estimated market value of 6.44 USD Billion in 2024, the industry is expected to expand significantly, reaching 15.6 USD Billion by 2035. This growth trajectory indicates a robust compound annual growth rate (CAGR) of 8.36% from 2025 to 2035. Such projections reflect the increasing adoption of advanced information systems in oncology, driven by factors such as rising cancer incidence, technological advancements, and the growing demand for personalized medicine. This upward trend underscores the importance of investing in innovative solutions to enhance cancer care.

Rapid technological advancements in healthcare are significantly influencing the Global Oncology Information Systems Market Industry. Innovations such as artificial intelligence, machine learning, and big data analytics are transforming how oncology data is processed and utilized. These technologies enable more accurate diagnostics, personalized treatment plans, and improved patient outcomes. For example, AI-driven systems can analyze vast datasets to identify patterns that inform treatment decisions. As these technologies become more integrated into oncology practices, the market is expected to grow substantially, with projections indicating a rise to 15.6 USD Billion by 2035.

The integration of healthcare systems is a critical factor driving the Global Oncology Information Systems Market Industry. As healthcare providers strive for seamless data sharing and interoperability, the demand for comprehensive oncology information systems is on the rise. Integrated systems facilitate better communication among healthcare professionals, leading to improved patient care and outcomes. For example, electronic health records that incorporate oncology-specific data enable oncologists to access complete patient histories, enhancing treatment decisions. This trend towards integration is likely to accelerate market growth, as stakeholders recognize the value of cohesive data management in oncology.

Government initiatives aimed at improving cancer care and research are vital drivers of the Global Oncology Information Systems Market Industry. Many countries are increasing funding for cancer research and the development of healthcare infrastructure. For instance, the National Cancer Institute in the United States allocates significant resources to cancer research, which indirectly supports the adoption of oncology information systems. Such initiatives foster collaboration between public and private sectors, leading to the development of innovative solutions that enhance patient care. This supportive environment is likely to contribute to the market's growth trajectory, particularly as it approaches a projected CAGR of 8.36% from 2025 to 2035.

The shift towards personalized medicine is reshaping the Global Oncology Information Systems Market Industry. As treatment approaches become more tailored to individual patient profiles, the need for sophisticated information systems that can manage and analyze patient data becomes paramount. Personalized medicine relies heavily on genomic data and other biomarkers, necessitating robust data management solutions. This trend is evident in the increasing number of targeted therapies approved by regulatory bodies, which require precise tracking and management of patient responses. Consequently, the market is poised for growth as healthcare providers seek to implement systems that support personalized treatment strategies.

By region, the study provides the market insights for oncology information systems into North America, Europe, Asia-Pacific and Rest of the World. North America oncology information systems market accounted for USD 2.4 billion in 2023 with a share of around 45.80% and is expected to exhibit a significant CAGR growth during the study period due to the region's access to cutting-edge healthcare facilities and growing expertise in patient data management.

In addition, the market is influenced by factors such as the growing usage of these systems to monitor and record the treatment outcomes of cancer patients as well as the use of electronic medical records (EMR) in improving healthcare choices.

Further, the major countries studied in the market report for oncology information systems are: The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 3:  ONCOLOGY INFORMATION SYSTEMS MARKET SHARE BY REGION 2022 (%)

Source: Secondary Research, Primary Research, Market Research Future Database and Analyst Review

Asia Pacific oncology information systems market accounts for the second-largest market share due to favorable government programmes and increased public awareness of the OIS's advantages. In order to establish a grip in these lucrative areas, the firms vying for a sizable piece of this market must develop distinctive pricing policies as well as marketing plans specifically suited to this sector. Moreover, China market of oncology information systems held the largest market share, and the India market of oncology information systems was the fastest growing market in the region.

Europe oncology information systems market is expected to grow at the fastest CAGR from 2024 to 2032. The region's sophisticated healthcare infrastructure and growing understanding of patient information management are two important drivers of this progress. The demand for OIS in this region is also anticipated to rise because to the increasing requirement for dose management, treatment planning, and management of treatment schedules. Further, the UK market of oncology information systems held the largest market share, and the Germany market of oncology information systems was the fastest growing market in the region.

Major market players are spending a lot of money on R&D to increase their product lines, which will help the market of oncology information systems grow even more. Market participants are also taking a range of strategic initiatives to grow their worldwide footprint, with key market developments such as new product launches, contractual agreements, mergers and acquisitions, increased investments, and collaboration with other organizations. Competitors in the oncology information systems industry must offer cost-effective items to expand and survive in an increasingly competitive and rising market environment.

One of the primary business strategies adopted by manufacturers in the global oncology information systems industry to benefit clients and expand the market sector is to manufacture locally to reduce operating costs. In recent years, oncology information systems industry has provided medicine with some of the most significant benefits. The market of oncology information systems major player such as Altos Solutions, Elekta AB, Varian Medical Systems, Flatiron Health, RaySearch Laboratories, Epic Systems Corporation and Bogardus Medical Systems.

The Swedish business Elekta is a global leader in the development and manufacture of clinical management, radiation therapy, and radiosurgery-related equipment for the treatment of cancer and brain disorders. With more than 40 locations worldwide and about 4,700 workers, Elekta has a presence in more than 120 countries. In June 2021, to improve complete and individualised cancer care through precision oncology technologies, Elekta and Philips inked a contract to deepen their already successful strategic alliance.

American radiation oncology software and treatment provider Varian Medical Systems is situated in Palo Alto, California. Its medical equipment includes linear accelerators and software for radiation, radio-surgery, proton therapy, and brachytherapy in the treatment of cancer and other diseases. In September 2019, to hasten the creation of software tools that would enable precision medicine in radiation oncology, Varian established a cooperation with the privately held digital health business Oncora Medical.